Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Technology
J. Alas

23andMe Sells DNA Database to Regeneron in £256m Deal: Is Your Data Safe?

23andMe's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control and benefits.

Genetic information submitted by millions of 23andMe users is now in the hands of pharmaceutical giant Regeneron, following a £200 million acquisition deal.

Originally provided by customers seeking personal health or ancestry insights, the data may now be used to develop new drugs — with limited control or consent from the individuals it came from.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.